Page 105 - Demo

Parkinsonism in GNDs103253. De Coo IF, Renier WO, Ruitenbeek W, et al. A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome. Ann Neurol. Jan 1999;45(1):130-3. doi:10.1002/1531-8249(199901)45:1<130::aid-art21>3.3.co;2-q54. Sedel F, Ribeiro MJ, Remy P, Blau N, Saudubray JM, Agid Y. Dihydropteridine reductase deficiency: levodopa’s long-term effectiveness without dyskinesia. Neurology. Dec 26 2006;67(12):2243-5. doi:10.1212/01.wnl.0000249335.35585.3e55. Takahashi Y, Manabe Y, Nakano Y, et al. Parkinsonism in Association with Dihydropteridine Reductase Deficiency. Case Rep Neurol. Jan-Apr 2017;9(1):17-21. doi:10.1159/00045661056. Porta F, Mussa A, Concolino D, Spada M, Ponzone A. Dopamine agonists in dihydropteridine reductase deficiency. Mol Genet Metab. Apr 2012;105(4):582-4. doi:10.1016/j.ymgme.2012.01.01357. Straniero L, Guella I, Cilia R, et al. DNAJC12 and dopa-responsive nonprogressive parkinsonism. Ann Neurol. Oct 2017;82(4):640-646. doi:10.1002/ana.2504858. Anikster Y, Haack TB, Vilboux T, et al. Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability. Am J Hum Genet. Feb 2 2017;100(2):257-266. doi:10.1016/j.ajhg.2017.01.00259. Koroglu C, Baysal L, Cetinkaya M, Karasoy H, Tolun A. DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. Parkinsonism Relat Disord. Mar 2013;19(3):320-4. doi:10.1016/j.parkreldis.2012.11.00660. Ng J, Cortes-Saladelafont E, Abela L, et al. DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia. Mov Disord. May 30 2020;doi:10.1002/mds.2806361. Termsarasab P, Pearson TS. Juvenile Parkinsonism and epilepsy due to homozygous mutations in DNAJC6. Movement Disorders. 2015;30(SUPPL. 1):S459-S460. 19th International Congress of Parkinson’s Disease and Movement Disorders. San Diego, CA United States. (var.pagings). doi:http://dx.doi.org/10.1002/mds.2629562. Edvardson S, Cinnamon Y, Ta-Shma A, et al. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenileparkinsonism. PLoS One. 2012;7(5):e36458. doi:10.1371/journal.pone.003645863. Elsayed LE, Drouet V, Usenko T, et al. A Novel Nonsense Mutation in DNAJC6 Expands the Phenotype of Autosomal-Recessive Juvenile-Onset Parkinson’s Disease. Ann Neurol. Feb 2016;79(2):335-7. doi:10.1002/ana.2459164. Tassin J, Durr A, Bonnet AM, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain. Jun 2000;123 ( Pt 6):1112-21. doi:10.1093/brain/123.6.111265. Kikuchi A, Takeda A, Fujihara K, et al. Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report. Mov Disord. May 2004;19(5):590-3. doi:10.1002/mds.1071266. Wirth T, Mariani LL, Bergant G, et al. Loss-of-Function Mutations in NR4A2 Cause DopaResponsive Dystonia Parkinsonism. Mov Disord. May 2020;35(5):880-885. doi:10.1002/mds.2798267. Zielonka M, Makhseed N, Blau N, Bettendorf M, Hoffmann GF, Opladen T. Dopamine-Responsive Growth-Hormone Deficiency and Central Hypothyroidism in Sepiapterin Reductase Deficiency.JIMD Rep. 2015;24:109-13. doi:10.1007/8904_2015_45068. Bodhireddy S, Dickson DW, Mattiace L, Weidenheim KM. A case of Down’s syndrome with diffuse Lewy body disease and Alzheimer’s disease. Neurology. Jan 1994;44(1):159-61. doi:10.1212/wnl.44.1.15969. Brandel JP, Marconi R, Serdaru M, Vidailhet M, Agid Y. Down’s syndrome and Parkinson’s disease. Neurology. Dec 1994;44(12):2419-20. doi:10.1212/wnl.44.12.2419-c70. Agarwal P, Griffith AF, Borromeo-Wesner M. Case report and literature review of levodopareponsive young onset Parkinson’s disease in a patient with Down’s syndrome. Movement Disorders. 2010;25(SUPPL. 2):S499-S500. 14th International Congress of Parkinson’s Disease and Movement Disorders. Buenos Aires Argentina. (var.pagings). doi:http://dx.doi.org/10.1002/mds.2316271. Marui W, Iseki E, Kosaka K, Kato M, Adachi Y, Ueda K. An autopsied case of Down syndrome with Alzheimer pathology and alpha-synuclein immunoreactivity. Neuropathology. 1999;19(4):410-416. doi:http://dx.doi.org/10.1046/j.1440-1789.1999.00265.x